“Action is the true measure of intelligence!” said famous American author Napolean Hill, and Sun Pharmaceuticals Chairman and Managing Director Dilip Shanghvi has aptly demonstrated this statement! Sun Pharmaceuticals, India’s largest pharmaceutical company, is the result of his ability to act quickly on his decisions. It offers psychiatry, cardiology, gastroenterology, neurology, and diabetology therapeutic formulations.
Its global reach is demonstrated by the fact that it has 40 manufacturing facilities spread across the United States, Europe, Australia, Africa, and Asia! International markets account for 72 percent of Sun Pharma’s sales! Caracao Pharma of America and Taro Pharmaceutical Company of Israel were successfully acquired. It’s no surprise that Dilip Shanghvi is one of the world’s wealthiest people!
In 2016, the Indian government honoured him with the Padma Shri award.
Sun Pharma even completed a $4 billion merger with the well-known pharmaceutical brand Ranbaxy Laboratories Ltd. on March 25, 2015, a move that experts believe reveals the risk taker and savvy businessman in him. “Size is not something that excites us,” he says. The business’s quality and the opportunity to outperform the competition are both exciting!” Perhaps this is why the Pharmaceutical Industry’s Sun is shining brightly!
Shanghvi, Dilip Biography
Dilip Shanghvi is an Indian businessman, philanthropist, and pharmaceutical tycoon. His is an inspiring storey of determination, foresight, and ability! On October 1, 1955, he was born in the small Gujarat town of Amreli. Kumud and Shantilal Shanghvi were his parents. Shantilal Shanghvi, his father, was a wholesale drug distributor. DilipShanghvi, a Jain by faith, completed his education at JJ Ajmera High School before enrolling in the Bhawanipur Education Society. He then went on to Calcutta University to study Commerce and graduated!
Comments
Post a Comment